Healthcare expenditure of intravitreal anti‐vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema.
Saved in:
| Title: | Healthcare expenditure of intravitreal anti‐vascular endothelial growth factor inhibitors compared with dexamethasone implant for diabetic macular oedema. |
|---|---|
| Authors: | Hertzberg, Silvia NW1 (AUTHOR) s.n.w.hertzberg@medisin.uio.no, Moe, Morten Carstens1 (AUTHOR) m.c.moe@medisin.uio.no, Jørstad, Øystein Kalsnes1 (AUTHOR) OEYJOE@ous-hf.no, Petrovski, Beáta Éva1 (AUTHOR) beata.petrovski@medisin.uio.no, Burger, Emily2,3 (AUTHOR) e.a.burger@medisin.uio.no, Petrovski, Goran1 (AUTHOR) goran.petrovski@medisin.uio.no |
| Source: | Acta Ophthalmologica (1755375X). Dec2022, Vol. 100 Issue 8, pe1630-e1640. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
